News Image

Esperion Reports Fourth Quarter and Full Year 2024 Financial Results

Provided By GlobeNewswire

Last update: Mar 4, 2025

– FY24 Total Revenue Grew 186% Y/Y to $332.3 Million; FY24 U.S. Net Product Revenue Grew 48% Y/Y to $115.7 Million –

–Q4 Total Revenue Grew 114% Y/Y to $69.1 Million; Q4 U.S. Net Product Revenue Grew 52% Y/Y to $31.6 Million –

Read more at globenewswire.com

ESPERION THERAPEUTICS INC

NASDAQ:ESPR (7/15/2025, 9:56:54 AM)

1.185

+0.01 (+0.42%)



Find more stocks in the Stock Screener

Follow ChartMill for more